Benchmark Investment Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Parker-Hannifin
PH
|
+$924K |
| 2 |
W.W. Grainger
GWW
|
+$847K |
| 3 |
Uber
UBER
|
+$464K |
| 4 |
Analog Devices
ADI
|
+$430K |
| 5 |
Fortinet
FTNT
|
+$408K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$978K |
| 2 |
Quest Diagnostics
DGX
|
+$868K |
| 3 |
CVS Health
CVS
|
+$615K |
| 4 |
Tesla
TSLA
|
+$538K |
| 5 |
Centene
CNC
|
+$535K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 52.35% |
| 2 | Healthcare | 8.45% |
| 3 | Consumer Discretionary | 7.27% |
| 4 | Communication Services | 6.74% |
| 5 | Financials | 5.85% |
Similar funds
Benchmark Investment Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Benchmark Investment Advisors held 93 positions worth $99M, down 8.7% from $108M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Benchmark Investment Advisors withdrew a net $6.37M in Q3 2023, closing 15 positions and reducing 39 holdings. Its most notable exit was Quest Diagnostics, an estimated $868K position sold in full.
By sector, the portfolio is most concentrated in Technology at 52% of assets, up from 49% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Benchmark Investment Advisors opened a new position in Parker-Hannifin worth $895K.
- Benchmark Investment Advisors's largest Q3 2023 buy was Parker-Hannifin: 2,299 shares worth $895K.
- Benchmark Investment Advisors added most to Uber in Q3 2023, an estimated $464K increase.
- Benchmark Investment Advisors's biggest Q3 2023 reduction was UnitedHealth, cutting an estimated $978K.
- Benchmark Investment Advisors fully exited Quest Diagnostics in Q3 2023, selling an estimated $868K.
- Benchmark Investment Advisors's ten largest holdings make up 41% of its $99M portfolio in Q3 2023.
- Benchmark Investment Advisors opened 3 new positions and closed 15 in Q3 2023.
- Benchmark Investment Advisors's portfolio value fell 8.7% quarter-over-quarter to $99M.
Based on Benchmark Investment Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.